Thanks sKaTiNg_ANd_GirLS_DonT_mIx.
Interesting that Hunter has upgraded PLG to a buy.
Melanoma is one of a few diseases where treatment agents fear to thread.
Treatments have been in the main massive failures. It is the metastasis (migration of tumour cells) which makes it a deadly disease.
I am not sure how much Taxotere (chemo) they will be using in the combo P-88 drug.
NRT have found that that their combination Phenoxodiol + Cisplatin (chemo) uses only a fraction of the latter. They will be using it on another feared cancer: Ovarian.
I need to find out the dose PLG will be using in the US Melanoma Phase II trial.
_____________________________________
Thanks for the information, Redgumme; I am quite happy being a shareholder of both PLG and SPL.
Gerry
+ + data and comments + +, page-10
-
- There are more pages in this discussion • 48 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PGL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
43.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $71.64M | |||
| Open | High | Low | Value | Volume |
| 43.5¢ | 43.5¢ | 43.5¢ | $69.31K | 159.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 788030 | 43.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 44.0¢ | 95406 | 2 |
View Market Depth
| Last trade - 15.48pm 28/06/2024 (20 minute delay) ? |
| PGL (ASX) Chart |